Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v7-FR
Language French French
Date Updated 2021-04-13 2021-02-22
Drug Identification Number 02425165 02425165
Brand name AURO-GALANTAMINE ER AURO-GALANTAMINE ER
Common or Proper name Galantamine Hydrobromide Galantamine Hydrobromide
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients GALANTAMINE GALANTAMINE
Strength(s) 16MG 16MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30's 30's
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-01-18 2021-01-18
Estimated end date 2021-04-15 2021-03-30
Actual end date 2021-03-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Replaceable with Auro-Galantamine ER 16mg Cap 100 Btl Replaceable with Auro-Galantamine ER 16mg Cap 100 Btl
Health Canada comments